Evidence map›Paper›PMID 36511885›Full record

ArticleEuropean journal of translational myology2022

2023 On-site Padua Days on Muscle and Mobiliy Medicine: Call for speakers.

Sandra Zampieri, Carla Stecco, Marco Narici, Stefano Masiero, Ugo Carraro

Abstract readEditorial
In one paragraph

Article in European journal of translational myology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sandra ZampieriDepartment of Biomedical Sciences, University of Padova, Italy; Department of Surgery, Oncology, and Gastroenterology, University of Padova, Italy; CIR-Myo of the University of Padua, Italy; A&C M-C Foundation for Translational Myology, Padua. sanzamp@unipd.it.
Carla SteccoCIR-Myo of the University of Padua, Italy; Department of Neuroscience, Section of Human Anatomy, University of Padua. carla.stecco@unipd.it.
Marco NariciDepartment of Biomedical Sciences, University of Padova, Italy; CIR-Myo of the University of Padua. marco.narici@unipd.it.
Stefano MasieroCIR-Myo of the University of Padua, Italy; Department of Neuroscience, Physical Medicine and Rehabilitation School, University of Padua. stef.masiero@unipd.it.
Ugo CarraroDepartment of Biomedical Sciences, University of Padova, Italy; CIR-Myo of the University of Padua, Italy; A&C M-C Foundation for Translational Myology, Padua. ugo.carraro@unipd.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The winter of 2022 approaches with the need to finalize our plans for next year. This is urgent for the 2023 Meeting of the Padua Days of Muscle and Mobility Medicine (Pdm3) to be held March 29th to April 1st, 2023 at the Hotel Petrarca in the Thermae of Euganean Hills (Padua), Italy. A preliminary Pdm3 Program is almost ready with sessions, organzers and keynote speakers, but ther is still rooms for many interesting and interested young speakers. Some of the Pdm3 sessions dedicated to molecular and cellular myology are organized by old Pdm3 Friends, but there will also be interesting new entries, including those for Rehabilitation Sessions. No doubt that 2023 Pdm3 will attract old friends, but topics of a few sessions are at the frontiers of Translational Myology and new entries are most warmly acknowledged. This is true for both basic myology research, which include beside traditional MiRNA the new entry of the LNC-RNA and the "dark side of the genome". As to rehabilitation topics, beside the old friends of the "LBI workshop on muscle rehabilitation - from mouse to elderly", new entries are sessions on Muscle Fascia, Muscle Rehabilitation in Dentistry (that will organize also a Practical Course) and the session on "European Medical Thermalism and FEMTEC" that will also offer a practical Course. We hope that by January 20th, 2023 many old and new friends will send their abstracts to fill an half-empty program and then by May 1st, 2023 they submit Communications to EJTM that deserve them to increase the 2023 EJTM Impact Factor.

Identifiers

PMID36511885
PMCPMC9830393

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.